Publicidad
Caso clínico 02 de octubre de 2012

Utilidad del PET-RNM cerebral en la reestadificación de un cáncer de sigmoides con metástasis cerebrales

Referenciar Imprimir Descargar PDF

Referencias

  1. Cante D, Girelli G, La Porta MR, et al. Late brain metastases from colorectal cancer. A case report and review of the literature. Tumori 20015;91:280-2.
  2. Andrea G, Isidori A, Caroli E, et al. Single cerebral metastasis from colorectal adenocarcinoma. Neurosurg Rev 2004;27:55-7.
  3. Metástasis cerebral de adenocarcinoma colónico. Rev Esp Dig 2009;101:221-2.
  4. Ruiz-Hernandez G, Burzaco JA, Montz R, et al. PET-RNM en paciente con hidrocefalia y metástasis tratadas con radiocirugía. Oncología 2002;25:54-8.
  5. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain. A randomized trial. JAMA 1998;280:1485-9.
  6. Kondziolka D, Patel A, Lundsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45:427-34.
  7. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363:1665-72.
  8. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases. A randomized controlled trial. JAMA 2006;295:2483-91.
  9. Gang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery o radiosurgery plus whole brain irradiation: a randomized controlled trial. Lancet Oncol 2009;10:1037-44.
  10. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole brain radiotherapy following versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of the EORTC 22952-26002 study. J Clin Oncol 2011;29:134-41.
  11. Metha MP, Tsao MN, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology ( ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005;63:37-46.
  12. Maranzano E, Trippa F, Pacchiarini D, er al. Re-irradiation of brain metastases and metastatic spinal cord compression: clinical practice suggestions. Tumori 2005;91:325-30.
  13. Bahl A, Kumar M, Sharma D, et al. Reirradiation for progressive brain metastases. J Cancer Res Ther 2009;5:161-4.
  14. Chao S, Barnett GH, Vogelbaum MA, et al. Salvage stereotactic radiosurgery effectively treats recurrences from whole brain radiation therapy. Cancer 2008;113:2198-204.
  15. Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 2008;70:1350-60.
  16. Chen W. Clinical applications of PET in brain tumors. J Nucl Med 2007;48:1468-81.
  17. Belohlávek O, Simonova G, Kantorova I, et al. Brain metastases alter stereotactic radiosurgery using Leksell gamma Knife: can FDG PET help to differentiate radionecrosis from tumor progression? Eur J Nucl Med 2003;30:96-100.
  18. Tan H, Chen L, Guan Y, et al. Comparison of MRI, F-18 FDG and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy. Clin Nucl Med 2011;36:978-81.
  19. Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, et al. Differentiation between brain tumor and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy. Folia Neuropathol 2010;48:81-92.
  20. Kano H, Kondziolka D, Lobato-Polo J, et al. T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosugery 2010;66:486-92.